U.S. Food and Drug Administration

Cancer Liaison Program

Cancer News Releases: 1980s and 1990s

1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |1992 | 1991 | 1990 | 1989 | 1988 | 1987
Current Releases

1999

FDA Approves Celebrex for New Indication, to reduce the number of adenomatous colorectal polyps in familial adenomatous polyposis (FAP) (December 23)
FDA Approves New Indication for Taxotere, treating non-small cell lung cancer that does not respond to cisplatin-based chemotherapy (December 23)
FDA Takes Action Against Firm Marketing Unapproved Drugs (December 10)
FDA announced approval of Levulan Kerastick (aminolevulinic acid HCL) for Topical Solution, 20%, to be used in conjunction with photodyamic therapy for treatment of actinic keratoses (AKs) (pre-cancerous skin lesiions) of the face or scalp. This is the first combined drug and device treatment designed for targeted treatment that can be limited just to the lesion site(s) (December 6)
Mobile X-Ray Owner Sentenced in Mammogram Fraud Case (September 24)
FDA Approves New Chemotherapy Agent to Treat Breast Cancer (September 16)
FDA Issues Final Rule on OTC Drug Products containing Colloidal Silver (August 17)
FDA Approves New Drug for Brain Cancer (August 11)
FDA Announces New Efforts to Help Curb Illegal Prescription Drug Marketing on the Internet (July 30)
Mamogram Law Takes Effect April 28 (April 27)
Dietary Supplements Now Labeled with More Information (March 23)
FDA Approves Novel Treatment for Rare Form of Cancer (February 5)

1998

New Monoclonal Antibody (Herceptin) Approved for Advanced Breast Cancer (September 25)
FDA Approves New Mammography Screening Aids (June 29)
FDA Approves First Automated System for Primary Screening of PAP Smears (May 5)
FDA Approves Xeloda for Breast Cancer (April 30)
Statement by FDA Lead Commissioner, Michael A. Freidman, M.D. NCI Breast Cancer Prevention Trial Study, (tamoxifen, Nolvadex) (April 6)

1997

First Monoclonal Antibody Approved to Treat Cancer (November 26)
New Biotech Product Approved to Reduce Need for Chemotherapy-Related Platelet Transfusions (November 25)
FDA Issues Final Standards for Mammography Facilities (October 27)
GAO Report on Mammography Inspections (January 20)

1996

FDA Approves New Use for Drug in Treating Prostate Cancer (November 13)
FDA Lists All Certified Mammography Facilities on the Internet (October 30)
FDA Approves New Brain Cancer Treatment (September 24)
FDA Licenses Diagnostic Imaging Agent for Lung Cancer (August 20)
FDA Names New Director for Cancer Drugs Division (August 3)
FDA Approves Drug for Advanced Colorectal Cancer (June 17)
FDA Approves Ovarian Cancer Drug (May 29)
FDA Approves Drug for Pancreatic Cancer (May 16)
FDA Approves Taxotere for Breast Cancer (May 15)
FDA Approves New Device to Treat Enlarged Prostate (May 6)
FDA Approves First Blood Test for Breast Cancer Recurrence (April 1)
FDA Proposes Final Mammography Standards (March 29)

1995

FDA 1995 Approvals Show Continued Decline in Review Times (January 16)
FDA Approves Sensorpad as Aid in Self Examination of Breasts (December 22)
FDA Approves New PAP Smear Screening System (October 3)
FDA Expands Access to Experimental Treatment for Advanced Renal Cell Cancer (September 26)
TDA and Polyurethane Breast Implants (June 28)
Saline Breast Implant Information Update (June 28)
Mammography Facility Locator Service Opens (May 12)
FDA Authorizes Treatment IND for Advanced Pancreatic Cancer (February 17)

1994

FDA Approves Drug for Non Small Cell Lung Cancer (December 27)
Saline Filled Breast Implant Update (December 23)
Mammography Quality Deadline Oct 1, 1994 (September 29)
Panel Recommends Studies for Breast Self Exam Devices (September 1)
FDA Approves Test for Prostate Cancer (August 29)
Advisory Committee Reevaluates Tamoxifen Prevention Trial (June 7)
Breast Implant Update (June 1)
FDA Approves Treatment IND for Non Small Cell Lung Cancer (May 3)
Taxol Approved for Breast Cancer (April 21)
Stronger warning to women and doctors that tamoxifen poses an increased risk of cancer of the uterus (April 8)

1993

Clinton Amends the 1992 Mammography Quality Standards Act (December 14)
Sunscreen labeling requirements (May 12)
Immunology Studies on Silicone Gel (March 22)
One Treatment Intravenous Drug for Hairy Cell Leukemia (March 2)

1992

New rules to speed the approval of drugs for patients with serious or life threatening illnesses such as AIDS, cancer and Alzheimer s disease (December 8)
FDA Advisory Committee Recommends Taxol for Ovarian Cancer (November 18)
FDA Urges Women to Get High Quality Mammography (November 17)
FDA Approves Clinical Studies of Silicone Breast Implants (August 3)
License Granted for Aldesleukin for Treatment of Metastic Renal Cell Carcinoma Kidney Cancer (May 5)
Breast Implants Available only under Controlled Clinical Studies (April 16)
Panel Makes Breast Implant Recommendations (February 20)
FDA Sets Up Toll Free Phone Line on Breast Implants (February 18)
FDA calls for a Moratorium on the use of Silicone Gel Breast Implants (January 6)

1991

Panel Issues Breast Implant Recommendations (November 15)
FDA Advises Doctors to Provide Risk Information on Breast Implants (September 25)
FDA Advisory Committee Meeting on Polyurethane Coated Breast Implants (August 1)
Manufacturers of Breast Implants Submit Data for Review (July 11)
Treatment IND for Drug to Treat Leukemia (June 21)
Silicone Breast Implants (April 10)
G CSF Approved to Protect Cancer Chemo Patients (February 21)

1990

Mammography (December 4)
BCG for cancer (May 21)
Levamisole Approved (June 20)
Breast Cancer Drug Approval (June 25)
Breast Implants (April 17)
Treatment IND Update (March 20)

1989

Treatment IND for Leukemia (December 1)
Flutamide Approved for Prostate Cancer (January 30)

1988

Making Drugs Available for Life Threatening Diseases (October 19)

1987

horizontal rule

Cancer Liaison Program Home Page